University of California San Francisco

Melissa Zimel MD 144x192
Melissa Zimel, MD

Associate Professor, Orthopaedic Surgery

Address

1825 4th Street, #L6101
San Francisco, CA 94107
United States

Email: [email protected]
Phone: 415-885-3800
Fax: 415-514-5661

ORCID: 0000-0003-0089-3753

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2018
Memorial Sloan Kettering Cancer Center Orthopaedic Oncology 07/2015
William Beaumont Hospital Orthopaedic Surgery 06/2013
Northwestern University Feinberg School of Medicine MD Medicine 05/2008
University of Southern California BA Biology, Philosophy 05/2004

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 23
  1. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
    Schott CR, Koehne AL, Sayles LC, Young EP, Luck C, Yu K, Lee AG, Breese MR, Leung SG, Xu H, Shah AT, Liu HY, Spillinger A, Behroozfard IH, Marini KD, Dinh PT, Pons Ventura MV, Vanderboon EN, Hazard FK, Cho SJ, Avedian RS, Mohler DG, Zimel M, Wustrack R, Curtis C, Sirota M, Sweet-Cordero EA| | PubMed
  2. Botryomycosis: a rare mimic of sarcoma as an initial presentation of acquired immunodeficiency syndrome.
    Boone SL, Horvai AE, Zimel MN, Brown R, Link TM, McGill KC| | PubMed
  3. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
    Jackson KJ, Sullivan CD, Zimel MN, Wustrack RL, PARITY Investigators| | PubMed
  4. Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities.
    Schott CR, Koehne AL, Sayles LC, Young EP, Luck C, Yu K, Lee AG, Breese MR, Leung SG, Xu H, Shah AT, Liu HY, Spillinger A, Behroozfard IH, Marini KD, Dinh PT, Pons Ventura MAV, Vanderboon EN, Hazard FK, Cho SJ, Avedian RS, Mohler DG, Zimel M, Wustrack R, Curtis C, Sirota M, Sweet-Cordero EA| | PubMed
  5. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
    von Mehren M, Kane JM, Riedel RF, Sicklick JK, Pollack SM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Poppe M, Schuetze S, Shabason J, Spraker MB, Zimel M, Bergman MA, Sundar H, Hang LE| | PubMed
  6. Survival and failure modes of the Compress® spindle and expandable distal femur endoprosthesis among pediatric patients: A multi-institutional study.
    Tanaka KS, Andaya VR, Thorpe SW, Gundle KR, Hayden JB, Duong YC, Avedian RS, Mohler DG, Morse LJ, Zimel MN, O'Donnell RJ, Fang A, Randall RL, Tran TH, New C, Wustrack RL, other members of Study Group FORCE| | PubMed
  7. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Pollack SM, Poppe M, Riedel RF, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Hang LE, Sundar H, Bergman MA| | PubMed
  8. Diagnosis and management of pediatric primary bone tumors in the emergency department.
    Nik-Ahd M, Agrawal AK, Zimel M| | PubMed
  9. Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma.
    Wustrack RL, Shao E, Sheridan J, Zimel M, Cho SJ, Horvai AE, Luong D, Kwek SS, Fong L, Okimoto RA| | PubMed
  10. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.
    von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Meyer C, Pappo AS, Parkes AM, Paz IB, Petersen IA, Poppe M, Riedel RF, Rubin B, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Bergman MA, George GV| | PubMed
23
View all 23 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 23
  1. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
    Schott CR, Koehne AL, Sayles LC, Young EP, Luck C, Yu K, Lee AG, Breese MR, Leung SG, Xu H, Shah AT, Liu HY, Spillinger A, Behroozfard IH, Marini KD, Dinh PT, Pons Ventura MV, Vanderboon EN, Hazard FK, Cho SJ, Avedian RS, Mohler DG, Zimel M, Wustrack R, Curtis C, Sirota M, Sweet-Cordero EA| | PubMed
  2. Botryomycosis: a rare mimic of sarcoma as an initial presentation of acquired immunodeficiency syndrome.
    Boone SL, Horvai AE, Zimel MN, Brown R, Link TM, McGill KC| | PubMed
  3. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
    Jackson KJ, Sullivan CD, Zimel MN, Wustrack RL, PARITY Investigators| | PubMed
  4. Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities.
    Schott CR, Koehne AL, Sayles LC, Young EP, Luck C, Yu K, Lee AG, Breese MR, Leung SG, Xu H, Shah AT, Liu HY, Spillinger A, Behroozfard IH, Marini KD, Dinh PT, Pons Ventura MAV, Vanderboon EN, Hazard FK, Cho SJ, Avedian RS, Mohler DG, Zimel M, Wustrack R, Curtis C, Sirota M, Sweet-Cordero EA| | PubMed
  5. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
    von Mehren M, Kane JM, Riedel RF, Sicklick JK, Pollack SM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Poppe M, Schuetze S, Shabason J, Spraker MB, Zimel M, Bergman MA, Sundar H, Hang LE| | PubMed
  6. Survival and failure modes of the Compress® spindle and expandable distal femur endoprosthesis among pediatric patients: A multi-institutional study.
    Tanaka KS, Andaya VR, Thorpe SW, Gundle KR, Hayden JB, Duong YC, Avedian RS, Mohler DG, Morse LJ, Zimel MN, O'Donnell RJ, Fang A, Randall RL, Tran TH, New C, Wustrack RL, other members of Study Group FORCE| | PubMed
  7. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Pollack SM, Poppe M, Riedel RF, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Hang LE, Sundar H, Bergman MA| | PubMed
  8. Diagnosis and management of pediatric primary bone tumors in the emergency department.
    Nik-Ahd M, Agrawal AK, Zimel M| | PubMed
  9. Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma.
    Wustrack RL, Shao E, Sheridan J, Zimel M, Cho SJ, Horvai AE, Luong D, Kwek SS, Fong L, Okimoto RA| | PubMed
  10. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.
    von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Meyer C, Pappo AS, Parkes AM, Paz IB, Petersen IA, Poppe M, Riedel RF, Rubin B, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Bergman MA, George GV| | PubMed
  11. Outcomes of Elderly Patients with Soft Tissue Sarcoma of the Extremities
    Chew J, Lloyd SA, Okimoto RA, Sabnis A, Nakakura E, Corvera C, Zimel MN, Horvai AE, Cho SJ, Wustrack RL, Braunstein SE.| | UCSF Research Profile
  12. Fibroma-like perivascular epithelioid cell tumor: a rare case in a long bone.
    Ramezanpour S, Horvai AE, Zimel M, Bucknor M, Link TM| | PubMed
  13. Intraoperative Radiotherapy Without External Beam Radiotherapy in the Management of Primary Soft Tissue Sarcomas of the Extremities
    Chen WS, Lometti M, Wustrack RL, Zimel MN, O'Donnell RJ, Horvai AE, Cho SJ, Okimoto RA, Jahan TM, Gottschalk AR, Braunstein SE.| | UCSF Research Profile
  14. Risk of Endoprosthetic Infection and Impact of Health-Related Quality of Life in Patients with Osteosarcoma and Giant Cell Tumor of Bone; a Retrospective Case-Control Study
    Butte Z, Tanaka K, Andaya V, Zimel M, O'Donnell R, Wustrack R. Ann Joint 2020; 5:27| | UCSF Research Profile
  15. Cutibacterium (formerly Propionibacterium) acnes clavicular infection.
    Zaid M, Chavez MR, Carrasco AE, Zimel MN, Zhang AL, Horvai AE, Link TM, O'Donnell RJ| | PubMed
  16. A Biomechanical and Structural Comparison of Articular Cartilage and Subchondral Bone of the Glenoid and Humeral Head.
    Loy BN, Zimel M, Gowda AL, Tooley TR, Maerz T, Bicos J, Guettler J| | PubMed
  17. Considerations for the Long Term Treatment of Pediatric Sarcoma Survivors.
    Weiss KR, Zimel MN| | PubMed
  18. HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer.
    Zimel MN, Horowitz CB, Rajasekhar VK, Christ AB, Wei X, Wu J, Wojnarowicz PM, Wang D, Goldring SR, Purdue PE, Healey JH| | PubMed
  19. Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.
    Nakajima K, Kho DH, Yanagawa T, Zimel M, Heath E, Hogan V, Raz A| | PubMed
  20. Revision Distal Femoral Arthroplasty With the Compress(®) Prosthesis Has a Low Rate of Mechanical Failure at 10 Years.
    Zimel MN, Farfalli GL, Zindman AM, Riedel ER, Morris CD, Boland PJ, Healey JH| | PubMed
  21. Carbon fiber intramedullary nails reduce artifact in postoperative advanced imaging.
    Zimel MN, Hwang S, Riedel ER, Healey JH| | PubMed
  22. Reverse total shoulder arthroplasty for the management of failed shoulder arthroplasty with proximal humeral bone loss: is allograft augmentation necessary?
    Budge MD, Moravek JE, Zimel MN, Nolan EM, Wiater JM| | PubMed
  23. Megaprosthesis versus Condyle-sparing intercalary allograft: distal femoral sarcoma.
    Zimel MN, Cizik AM, Rapp TB, Weisstein JS, Conrad EU| | PubMed